HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.

Abstract
Wet preparation has limited sensitivity for diagnosis of Trichomonas vaginalis (TV) infection. An observational study of 337 women was conducted to evaluate a new polymerase chain reaction (PCR) test for TV. The sensitivities of wet preparation and TV culture were 52% (95% confidence interval [CI], 41-62) and 78% (95% CI, 69-86), respectively. TV PCR had a sensitivity of 84% (95% CI, 75-90) and a specificity of 94% (95% CI, 90-97). Metronidazole was provided to 67 (69%) of 97 women with TV because of TV on wet preparation, exposure to TV, or a diagnosis of bacterial vaginosis or pelvic inflammatory disease; however, if TV PCR had been used for diagnosis, 81 (84%) of 97 women with TV would have been treated (P=.02). TV is significantly undertreated using standard algorithms for metronidazole therapy. Given the association of trichomoniasis with perinatal morbidity and HIV transmission, women in high-risk groups may benefit from TV PCR.
AuthorsKaren A Wendel, Emily J Erbelding, Charlotte A Gaydos, Anne M Rompalo
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 35 Issue 5 Pg. 576-80 (Sep 01 2002) ISSN: 1537-6591 [Electronic] United States
PMID12173132 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antitrichomonal Agents
  • Metronidazole
Topics
  • Adolescent
  • Adult
  • Animals
  • Antitrichomonal Agents (therapeutic use)
  • Female
  • Humans
  • Metronidazole (therapeutic use)
  • Middle Aged
  • Polymerase Chain Reaction
  • Sexually Transmitted Diseases (drug therapy, epidemiology, parasitology)
  • Trichomonas Vaginitis (drug therapy, epidemiology, parasitology, transmission)
  • Trichomonas vaginalis (genetics, isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: